Optimal doses of antidepressants in dependence on age: Combined covariate actions in Bayesian network meta-analysis
Author:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 18, 100219
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Evidence Synthesis for Decision Making 3Medical Decision Making, 2013
- Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-AnalysisAmerican Journal of Psychiatry, 2013
- Age-Related Changes in Antidepressant Pharmacokinetics and Potential Drug-Drug Interactions: A Comparison of Evidence-Based Literature and Package Insert InformationThe American Journal of Geriatric Pharmacotherapy, 2012
- Efficacy of Antidepressants for Late-Life DepressionThe Journal of Clinical Psychiatry, 2011
- Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot studyBMC Psychiatry, 2011
- National Patterns in Antidepressant Medication TreatmentArchives of General Psychiatry, 2009
- Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the EvidenceThe American Journal of Geriatric Psychiatry, 2008
- Bayesian Measures of Model Complexity and FitJournal of the Royal Statistical Society Series B: Statistical Methodology, 2002
- Effectiveness of antidepressantsThe British Journal of Psychiatry, 1999
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960